Sökfunktioner

Personalkatalog

Sök

Lista institutioner och enheter i Institutioner och enheter i bokstavsordning sorteringsordning eller efter kategori

Andreas Josefsson

Kontaktinformation
Befattning:	Forskare
Verksam vid:	Medicinsk biovetenskap
Avdelning:	Patologi
Adress:	Umeå universitet SE-901 85 Umeå Sverige
Besöksadress:	By 6M, Sjukhusområdet
E-postadress:	andreas.josefsson@medbio.umu.se E-post

Publikationer

Sida 1 av 2
- Föregående
- 1
- 2
- Nästa
Visa alla

Författare	Titel	År	Fulltext
Mirtti, Tuomas Leiby, Benjamin E. Abdulghani, Junaid; et al.	Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy Human Pathology, 44(3): 310-319	2013	-
Hammarsten, Peter Cipriano, Mariateresa Josefsson, Andreas; et al.	Phospho-Akt Immunoreactivity in Prostate Cancer: Relationship to Disease Severity and Outcome, Ki67 and Phosphorylated EGFR Expression PLoS ONE, 7(10): e47994-	2012	Hämta
Josefsson, Andreas Wikstrom, Pernilla Egevad, Lars; et al.	Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance Scandinavian Journal of Urology and Nephrology, 46(4): 247-257	2012	-
Josefsson, Andreas	Prognostic markers in prostate cancer: studies of a watchful waiting cohort with long follow up	2011	Hämta
Thomasson, Marcus Wang, Baofeng Hammarsten, Peter; et al.	LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer. International Journal of Cancer, 128(12): 2843-2852	2011	-
Josefsson, Andreas Adamo, Hani Hammarsten, Peter; et al.	Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome American Journal of Pathology, 179(4): 1961-1968	2011	-
Hammarsten, Peter Karalija, Amar Josefsson, Andreas; et al.	Low levels of phosphorylated epidermal growth factor receptor in nonmalignant and malignant prostate tissue predict favorable outcome in prostate cancer patients. Clinical Cancer Research, 16(4): 1245-1255	2010	-
Hägglöf, Christina Hammarsten, Peter Josefsson, Andreas; et al.	Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival PLoS ONE, 5(5): e10747-	2010	-
Chung, Sui Chu Hammarsten, Peter Josefsson, Andreas; et al.	A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer European Journal of Cancer, 45(1): 174-182	2009	-
Josefsson, Andreas Wikström, Pernilla Granfors, Torvald; et al.	Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment European Urology, 48(4): 577-583	2005	-

Sidansvarig: Åsa Lundsten
2010-11-02